Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 4;17(3):638-643.
doi: 10.1080/21645515.2020.1818519. Epub 2020 Oct 16.

The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization

Caitlyn Kellogg  1   2 , Ozlem Equils  2
Affiliations
Review

The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization

Caitlyn Kellogg et al. Hum Vaccin Immunother. .

Abstract

The thymus is a largely neglected organ but plays a significant role in the regulation of adaptive immune responses. The effect of aging on the thymus and immune senescence is well established, and the resulting inflammaging is found to be implicated in the development of many chronic diseases including atherosclerosis, hypertension and type 2 diabetes. Both aging and diseases of inflammaging are associated with severe COVID-19 disease, and a dysfunctional thymus may be a predisposing factor. In addition, insults on the thymus during childhood may lead to abnormal thymic function and may explain severe COVID-19 disease among younger individuals; therefore, measurement of thymic function may assist COVID-19 care. Those with poor thymic function may be treated prophylactically with convalescent serum or recombinant antibodies, and they may respond better to high-dose or adjuvanted COVID-19 vaccines. Treatments inducing thymic regeneration may improve patients' overall health and may be incorporated in COVID-19 management.

Keywords: COVID-19; aging; immunity; immunosenescence; inflammation; longevity; thymus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dai X, Zhang D, Wang C, Wu Z, Liang C.. The pivotal role of thymus in atherosclerosis mediated by immune and inflammatory response. Int J Med Sci. 2018;15(13):1555–63. doi:10.7150/ijms.27238. - DOI - PMC - PubMed
    1. Dai X, Hua L, Chen Y, Wang J, Li J, Wu F, Zhang Y, Su J, Wu Z, Liang C. Mechanisms in hypertension and target organ damage: is the role of the thymus key? (Review). Int J Mol Med. 2018;42(1):3–12. doi:10.3892/ijmm.2018.3605. - DOI - PMC - PubMed
    1. Ying S, O’Connor B, Ratoff J, Meng Q, Fang C, Cousins D, Zhang G, Gu S, Gao Z, Shamji B, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008;181(4):2790–98. doi:10.4049/jimmunol.181.4.2790. - DOI - PubMed
    1. Cosway E, Anderson G, Garside P, Prendergast C. The thymus and rheumatology: should we care? Curr Opin Rheumatol. 2016;28(2):189–95. doi:10.1097/BOR.0000000000000251. - DOI - PMC - PubMed
    1. Killerby ME, Link-Gelles R, Haight SC, Schrodt CA, England L, Gomes DJ, Shamout M, Pettrone K, O’Laughlin K, Kimball A, et al. Characteristics associated with hospitalization among patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):790–94. doi:10.15585/mmwr.mm6925e1. - DOI - PMC - PubMed

Publication types

Grants and funding

This work was supported by MiOra public health education nonprofit.